Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""H1"" wg kryterium: Temat


Tytuł :
Risk factors of uncontrolled symptoms using the standard dose of second-generation H1 -antihistamines in chronic spontaneous urticaria children.
Autorzy :
Koosakulchai V; Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Yuenyongviwat A; Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Sangsupawanich P; Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Pokaż więcej
Źródło :
Asian Pacific journal of allergy and immunology [Asian Pac J Allergy Immunol] 2022 Jun; Vol. 40 (2), pp. 121-125.
Typ publikacji :
Journal Article
MeSH Terms :
Chronic Urticaria*/drug therapy
Exanthema*/chemically induced
Exanthema*/drug therapy
Histamine H1 Antagonists, Non-Sedating*/therapeutic use
Urticaria*/drug therapy
Child ; Chronic Disease ; Histamine H1 Antagonists/adverse effects ; Humans ; Omalizumab/therapeutic use ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Cold urticaria in a pediatric cohort: Clinical characteristics, management, and natural history.
Autorzy :
Prosty C; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Gabrielli S; Faculty of Medicine, McGill University, Montreal, QC, Canada.; Division of Pediatric Allergy, Immunology, and Dermatology, Montreal Children's Hospital, Montreal, QC, Canada.
Mule P; Division of Pediatric Allergy, Immunology, and Dermatology, Montreal Children's Hospital, Montreal, QC, Canada.
Le Gallee M; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Miles LM; Division of Pediatric Allergy, Immunology, and Dermatology, Montreal Children's Hospital, Montreal, QC, Canada.
Le M; Division of Dermatology, McGill University, Montreal, QC, Canada.
Zhang X; Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, QC, Canada.
Ensina LF; Division of Allergy, Clinical Immunology, and Rheumatology, Federal University of Sao Paulo, Sao Paulo, Brazil.
Netchiporouk E; Division of Dermatology, McGill University, Montreal, QC, Canada.
Ben-Shoshan M; Division of Pediatric Allergy, Immunology, and Dermatology, Montreal Children's Hospital, Montreal, QC, Canada.
Pokaż więcej
Źródło :
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2022 Mar; Vol. 33 (3), pp. e13751.
Typ publikacji :
Journal Article
MeSH Terms :
Chronic Urticaria*
Histamine H1 Antagonists, Non-Sedating*
Urticaria*/diagnosis
Urticaria*/drug therapy
Urticaria*/epidemiology
Child ; Chronic Disease ; Cohort Studies ; Comorbidity ; Female ; Humans
Czasopismo naukowe
Tytuł :
Epigallocatechin gallate stimulated histamine production and downregulated histamine H1 receptor in oral cancer cell lines expressing histidine decarboxylase.
Autorzy :
Kon M; Division of Oral and Maxillofacial Surgery, Department of Oral Surgery, Iwate Medical University, Iwate, Japan; Division of Bioregulatory Pharmacology, Department of Pharmacology, Iwate Medical University, Iwate, Japan.
Ishikawa T; Division of Molecular Microbiology, Department of Microbiology, Iwate Medical University, Iwate, Japan.
Ohashi Y; Division of Oral and Maxillofacial Surgery, Department of Oral Surgery, Iwate Medical University, Iwate, Japan.
Yamada H; Division of Oral and Maxillofacial Surgery, Department of Oral Surgery, Iwate Medical University, Iwate, Japan.
Ogasawara M; Division of Bioregulatory Pharmacology, Department of Pharmacology, Iwate Medical University, Iwate, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of oral biosciences [J Oral Biosci] 2022 Mar; Vol. 64 (1), pp. 120-130. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mouth Neoplasms*/drug therapy
Receptors, Histamine H1*/genetics
Catechin/analogs & derivatives ; Cell Line ; Histamine/metabolism ; Histidine Decarboxylase ; Humans ; Receptors, Cell Surface
Czasopismo naukowe
Tytuł :
The Skeletal Muscle Relaxer Cyclobenzaprine Is a Potent Non-Competitive Antagonist of Histamine H1 Receptors.
Autorzy :
Singh K; Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, Georgia (K.S., I.S.S., A.C., P.F.K., N.H.M.) and Department of Biomedical Sciences, School of Medicine, Mercer University Health Sciences Center, Mercer University, Macon, Georgia (N.H.M.).
Senatorov IS; Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, Georgia (K.S., I.S.S., A.C., P.F.K., N.H.M.) and Department of Biomedical Sciences, School of Medicine, Mercer University Health Sciences Center, Mercer University, Macon, Georgia (N.H.M.).
Cheshmehkani A; Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, Georgia (K.S., I.S.S., A.C., P.F.K., N.H.M.) and Department of Biomedical Sciences, School of Medicine, Mercer University Health Sciences Center, Mercer University, Macon, Georgia (N.H.M.).
Karmokar PF; Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, Georgia (K.S., I.S.S., A.C., P.F.K., N.H.M.) and Department of Biomedical Sciences, School of Medicine, Mercer University Health Sciences Center, Mercer University, Macon, Georgia (N.H.M.).
Moniri NH; Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, Georgia (K.S., I.S.S., A.C., P.F.K., N.H.M.) and Department of Biomedical Sciences, School of Medicine, Mercer University Health Sciences Center, Mercer University, Macon, Georgia (N.H.M.) .
Pokaż więcej
Źródło :
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 Mar; Vol. 380 (3), pp. 202-209. Date of Electronic Publication: 2022 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Amitriptyline*/analogs & derivatives
Amitriptyline*/pharmacology
Receptors, Histamine H1*
Animals ; Humans ; Mice ; Muscle, Skeletal ; Rats
Czasopismo naukowe
Tytuł :
Pharmacokinetics of diphenhydramine following single-dose intravenous and oral administration in non-fasted adult horses.
Autorzy :
Redmond JS; Department of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Stang BV; Department of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Schlipf JW Jr; Department of Clinical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, Oregon, USA.
Christensen JM; College of Pharmacy, Oregon State University, Corvallis, Oregon, USA.
Pokaż więcej
Źródło :
Journal of veterinary pharmacology and therapeutics [J Vet Pharmacol Ther] 2022 Mar; Vol. 45 (2), pp. 188-195. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji :
Journal Article
MeSH Terms :
Diphenhydramine*
Histamine H1 Antagonists*
Administration, Intravenous/veterinary ; Administration, Oral ; Animals ; Biological Availability ; Cross-Over Studies ; Dogs ; Horses
Czasopismo naukowe
Tytuł :
Histamine H 1 receptors regulate anhedonic-like behavior in rats: Involvement of the anterior cingulate and lateral entorhinal cortices.
Autorzy :
Ionov ID; Centre on Theoretical Problems in Physical and Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia. Electronic address: .
Pushinskaya II; Timpharm LTD, Moscow, Russia.
Gorev NP; Timpharm LTD, Moscow, Russia.
Shpilevaya LA; Timpharm LTD, Moscow, Russia.
Frenkel DD; Timpharm LTD, Moscow, Russia.
Severtsev NN; Timpharm LTD, Moscow, Russia.
Pokaż więcej
Źródło :
Behavioural brain research [Behav Brain Res] 2021 Aug 27; Vol. 412, pp. 113445. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji :
Journal Article
MeSH Terms :
Anhedonia/*physiology
Receptors, Histamine H1/*metabolism
Animals ; Brain/drug effects ; Brain/metabolism ; Gyrus Cinguli/metabolism ; Gyrus Cinguli/physiology ; Histamine/metabolism ; Histamine Agonists/pharmacology ; Histamine H1 Antagonists/pharmacology ; Male ; Olfactory Cortex/metabolism ; Olfactory Cortex/physiology ; Rats ; Rats, Wistar ; Receptors, Histamine H1/physiology
Czasopismo naukowe
Tytuł :
A Novel Potent Sleep-Promoting Effect of Turmeric: Turmeric Increases Non-Rapid Eye Movement Sleep in Mice Via Histamine H 1 Receptor Blockade.
Autorzy :
Um MY; Research Division of Food Functionality, Korea Food Research Institute, Wanju, 55364, Republic of Korea.; Division of Food Biotechnology, University of Science & Technology, Daejeon, 34113, Republic of Korea.
Yoon M; Research Division of Food Functionality, Korea Food Research Institute, Wanju, 55364, Republic of Korea.
Lee J; Research Division of Food Functionality, Korea Food Research Institute, Wanju, 55364, Republic of Korea.
Jung J; Research Division of Food Functionality, Korea Food Research Institute, Wanju, 55364, Republic of Korea.
Cho S; Department of Food Science and Technology/Institute of Food Science, Pukyong National University, Busan, 48513, Republic of Korea.
Pokaż więcej
Źródło :
Molecular nutrition & food research [Mol Nutr Food Res] 2021 Jul; Vol. 65 (14), pp. e2100100. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Histamine H1 Antagonists/*pharmacology
Plant Extracts/*pharmacology
Sleep/*drug effects
Animals ; Curcuma ; Diazepam ; Doxepin ; Electroencephalography ; Hypnotics and Sedatives/pharmacology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Inbred ICR ; Mice, Knockout ; Polysomnography ; Receptors, Histamine H1/genetics ; Sleep Latency/drug effects ; Sleep, Slow-Wave
Czasopismo naukowe
Tytuł :
Desloratadine and loratadine use associated with improved melanoma survival.
Autorzy :
Fritz I; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Wagner P; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Bottai M; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institute, Solna, Sweden.
Eriksson H; Department of Oncology and Pathology, Karolinska Institute, Solna, Sweden.; Skin Cancer Center/Theme Cancer, Karolinska University Hospital, Solna, Sweden.; Department of Oncology/Theme Cancer, Karolinska University Hospital, Solna, Sweden.
Ingvar C; Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden.
Krakowski I; Department of Oncology and Pathology, Karolinska Institute, Solna, Sweden.; Department of Dermatology/Theme Inflammation, Karolinska University Hospital, Solna, Sweden.
Nielsen K; Department of Dermatology, Clinical Sciences, Lund University, Lund, Sweden.
Olsson H; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.; Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
Pokaż więcej
Źródło :
Allergy [Allergy] 2020 Aug; Vol. 75 (8), pp. 2096-2099. Date of Electronic Publication: 2020 Apr 16.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Histamine H1 Antagonists, Non-Sedating*
Melanoma*/drug therapy
Histamine H1 Antagonists ; Humans ; Loratadine/analogs & derivatives
Raport
Tytuł :
Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
Autorzy :
Qu C; Tomas Lindahl Nobel Laureate Laboratory, Precision Medicine Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.; Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
Fuhler GM; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, 3015 CN Rotterdam, The Netherlands.
Pan Y; Tomas Lindahl Nobel Laureate Laboratory, Precision Medicine Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 May 26; Vol. 22 (11). Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Inflammatory Agents/*pharmacology
Antiviral Agents/*pharmacology
COVID-19/*drug therapy
Histamine H1 Antagonists/*pharmacology
NF-kappa B/*metabolism
SARS-CoV-2/*drug effects
COVID-19/metabolism ; Humans ; Receptors, Histamine H1/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: A systematic literature review.
Autorzy :
Ngo E; PharmacoEpidemiology and Drug Safety, Department of Pharmacy, University of Oslo, Oslo, Norway.
Spigset O; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical Pharmacology, St. Olavs University Hospital, Trondheim, Norway.
Lupattelli A; PharmacoEpidemiology and Drug Safety, Department of Pharmacy, University of Oslo, Oslo, Norway.
Panchaud A; Service of Pharmacy, Lausanne University Hospital, Lausanne, Switzerland.; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Annaert P; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Allegaert K; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Clinical Pharmacy, Erasmus MC, Rotterdam, Netherlands.
Nordeng H; PharmacoEpidemiology and Drug Safety, Department of Pharmacy, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2022 Jan; Vol. 130 (1), pp. 171-181. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Breast Feeding*
Histamine H1 Antagonists/*pharmacokinetics
Milk, Human/*metabolism
Drug Labeling ; European Union ; Female ; Histamine H1 Antagonists/adverse effects ; Humans ; Infant ; Lactation ; United States
Czasopismo naukowe
Tytuł :
A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.
Autorzy :
Mohamad SA; Department of Pharmaceutics, Faculty of Pharmacy, Deraya University, Minia, Egypt.
Safwat MA; Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt.
Elrehany M; Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt.; Department of Biochemistry, Faculty of Medicine, Minia University, Minia, Egypt.
Maher SA; Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt.
Badawi AM; Department of Otorhinolaryngology, Faculty of Medicine, Minia University, Minia, Egypt.
Mansour HF; Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, Egypt.
Pokaż więcej
Źródło :
Drug delivery [Drug Deliv] 2021 Dec; Vol. 28 (1), pp. 229-239.
Typ publikacji :
Journal Article
MeSH Terms :
Emulsions*
Surface-Active Agents*
Dopamine Antagonists/*administration & dosage
Histamine H1 Antagonists, Non-Sedating/*administration & dosage
Loratadine/*administration & dosage
Nasal Mucosa/*drug effects
Rhinitis, Allergic/*metabolism
Sulpiride/*administration & dosage
Administration, Intranasal ; Animals ; Calorimetry, Differential Scanning ; Disease Models, Animal ; Dopamine Antagonists/pharmacology ; Drug Combinations ; Drug Liberation ; Glycerol ; Histamine H1 Antagonists, Non-Sedating/pharmacology ; In Vitro Techniques ; Interleukin-1/metabolism ; Lecithins ; Loratadine/pharmacology ; Nanostructures ; Nasal Mucosa/metabolism ; Olive Oil ; Ovalbumin ; Paranasal Sinuses/drug effects ; Paranasal Sinuses/metabolism ; Polysorbates ; Rabbits ; Rhinitis, Allergic/chemically induced ; Sodium Cholate ; Soybeans ; Spectroscopy, Fourier Transform Infrared ; Sulpiride/pharmacology ; Transforming Growth Factor beta/drug effects ; Transforming Growth Factor beta/metabolism ; Tumor Necrosis Factor-alpha/drug effects ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Long-term combinations and updosing of second-generation H 1 -antihistamines show efficacy and safety in the treatment of chronic spontaneous urticaria: A multicenter real-life pilot study.
Autorzy :
Zhang L; Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China.
Wu J; Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China.
Qi Y; Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China.
Zhu H; Department of Dermatology, Institute of Dermatology, Chinese Academy of Medical Science, Nanjing, China.
Yao X; Department of Dermatology, Institute of Dermatology, Chinese Academy of Medical Science, Nanjing, China.
Li M; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Li J; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Guo Z; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Su X; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Lai W; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Hao S; Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Li Y; Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Li Y; Department of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Yao C; Department of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Li F; Department of Dermatology, The Second Hospital of Jilin University, Changchun, China.
Wang H; Department of Dermatology, Tianjin Medical University General Hospital, Tianjin, China.
Liu Q; Department of Dermatology, Tianjin Medical University General Hospital, Tianjin, China.
Long H; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.
Lu Q; Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.
Gao X; Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China.
Chen H; Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China. Electronic address: .
Xiao T; Department of Dermatology, The First Hospital of China Medical University, National Health Commission Key Laboratory of Immunodermatology, Key Laboratory of Immunodermatology of Ministry of Education, Shenyang, China. Electronic address: .
Pokaż więcej
Źródło :
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2020 May; Vol. 8 (5), pp. 1733-1736.e11. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Chronic Urticaria*
Histamine H1 Antagonists, Non-Sedating*
Urticaria*/drug therapy
Chronic Disease ; Histamine Antagonists ; Histamine H1 Antagonists/therapeutic use ; Humans ; Pilot Projects
Czasopismo naukowe
Tytuł :
Histamine H1 receptor antagonists selectively kill cisplatin-resistant human cancer cells.
Autorzy :
Matsumoto N; Cell Regulation Laboratory, Bionics Program, Tokyo University of Technology Graduate School of Bionics, Computer and Media Science, Hachioji, Japan.
Ebihara M; School of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan.
Oishi S; School of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan.
Fujimoto Y; Cell Regulation Laboratory, Bionics Program, Tokyo University of Technology Graduate School of Bionics, Computer and Media Science, Hachioji, Japan.
Okada T; National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
Imamura T; Cell Regulation Laboratory, Bionics Program, Tokyo University of Technology Graduate School of Bionics, Computer and Media Science, Hachioji, Japan. .; School of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan. .; National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 Jan 15; Vol. 11 (1), pp. 1492. Date of Electronic Publication: 2021 Jan 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm/*physiology
Histamine H1 Antagonists/*pharmacology
Neoplasms/*metabolism
Apoptosis/drug effects ; Cell Line, Tumor ; Cisplatin/pharmacology ; Fibroblast Growth Factors/genetics ; Fibroblast Growth Factors/metabolism ; Gene Expression/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; HeLa Cells ; Histamine/pharmacology ; Histamine H1 Antagonists/metabolism ; Histamine H2 Antagonists/pharmacology ; Humans ; Neoplasms/drug therapy ; Piperidines/pharmacology ; Receptors, Histamine H1/genetics ; Receptors, Histamine H1/metabolism
Czasopismo naukowe
Tytuł :
Formulation and assessment of hydroxyzine HCL solid lipid nanoparticles by dual emulsification technique for transdermal delivery.
Autorzy :
El-Telbany DFA; Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, Egypt. Electronic address: .
El-Telbany RFA; Department of Biochemistry, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, Egypt. Electronic address: .
Zakaria S; Department of Pharmacology and Toxicology, Kafr Elsheikh University, Kafr Elsheikh, Egypt. Electronic address: .
Ahmed KA; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. Electronic address: .
El-Feky YA; Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, Egypt. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Nov; Vol. 143, pp. 112130. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Drug Carriers*
Nanoparticles*
Skin Absorption*
Antipruritics/*administration & dosage
Dermatitis, Atopic/*prevention & control
Histamine H1 Antagonists/*administration & dosage
Hydroxyzine/*administration & dosage
Lipids/*chemistry
Skin/*metabolism
Administration, Cutaneous ; Animals ; Antipruritics/chemistry ; Antipruritics/metabolism ; Dermatitis, Atopic/immunology ; Dermatitis, Atopic/metabolism ; Disease Models, Animal ; Drug Compounding ; Drug Liberation ; Gels ; Histamine H1 Antagonists/chemistry ; Histamine H1 Antagonists/metabolism ; Hydroxyzine/chemistry ; Hydroxyzine/metabolism ; Male ; Mice ; Nanotechnology ; Rats ; Surface Properties
Czasopismo naukowe
Tytuł :
Efficacy of Triprolidine in the Treatment of Temporary Sleep Disturbance.
Autorzy :
Cravo AS; Global Medical Affairs Senior Advisor (Respiratory), Reckitt Benckiser Healthcare Ltd, Slough, UK.
Shephard A; Global Marketing Director, Reckitt Benckiser Healthcare Ltd, Slough, UK.
Shea T; Senior Medical Scientist (Respiratory), Reckitt Benckiser Inc., Parsippany, New Jersey, USA.
Pokaż więcej
Źródło :
Journal of clinical pharmacology [J Clin Pharmacol] 2021 Sep; Vol. 61 (9), pp. 1156-1164. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Histamine H1 Antagonists/*therapeutic use
Sleep Wake Disorders/*drug therapy
Triprolidine/*therapeutic use
Adult ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Histamine H1 Antagonists/administration & dosage ; Histamine H1 Antagonists/adverse effects ; Humans ; Male ; Middle Aged ; Sleep Latency/drug effects ; Sleep Quality ; Triprolidine/administration & dosage ; Triprolidine/adverse effects
Czasopismo naukowe
Tytuł :
Connections between Immune-Derived Mediators and Sensory Nerves for Itch Sensation.
Autorzy :
Toyama S; Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Chiba 279-0021, Japan.
Tominaga M; Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Chiba 279-0021, Japan.; Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Chiba 279-0021, Japan.
Takamori K; Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Chiba 279-0021, Japan.; Anti-Aging Skin Research Laboratory, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Chiba 279-0021, Japan.; Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Chiba 279-0021, Japan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 16; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Histamine/*immunology
Immunologic Factors/*therapeutic use
Pruritus/*immunology
Receptors, Histamine H1/*immunology
Sensory Receptor Cells/*immunology
Antibodies, Monoclonal/therapeutic use ; Cytokines/antagonists & inhibitors ; Cytokines/immunology ; Cytokines/metabolism ; Gene Expression ; Histamine/metabolism ; Histamine Antagonists/therapeutic use ; Humans ; Lymphocytes/drug effects ; Lymphocytes/immunology ; Lymphocytes/pathology ; Myeloid Cells/drug effects ; Myeloid Cells/immunology ; Myeloid Cells/pathology ; Neuropeptides/antagonists & inhibitors ; Neuropeptides/immunology ; Neuropeptides/metabolism ; Peptide Hydrolases/immunology ; Peptide Hydrolases/metabolism ; Protease Inhibitors/therapeutic use ; Pruritus/drug therapy ; Pruritus/genetics ; Pruritus/pathology ; Receptors, Histamine H1/genetics ; Sensory Receptor Cells/drug effects ; Sensory Receptor Cells/pathology ; Skin/drug effects ; Skin/immunology ; Skin/innervation ; Skin/pathology
Czasopismo naukowe
Tytuł :
Fenebrutinib in H 1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial.
Autorzy :
Metz M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Allergology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
Sussman G; Division of Allergy and Clinical Immunology, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada.
Gagnon R; Service d'Allergie et Immunologie, Département de Médecine, Centre Hospitalier Universitaire de Québec, Quebec City, Québec, Canada.
Staubach P; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
Tanus T; Kern Allergy Medical Clinic Inc., Bakersfield, CA, USA.
Yang WH; Ottawa Allergy Research Corporation, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Lim JJ; Genentech, Inc., South San Francisco, CA, USA.
Clarke HJ; Genentech, Inc., South San Francisco, CA, USA.
Galanter J; Genentech, Inc., South San Francisco, CA, USA.
Chinn LW; Genentech, Inc., South San Francisco, CA, USA.
Chu T; Genentech, Inc., South San Francisco, CA, USA.
Teterina A; Hoffman-LaRoche Limited, Missisauga, Ontario, Canada.
Burgess T; Genentech, Inc., South San Francisco, CA, USA.
Haddon DJ; Genentech, Inc., South San Francisco, CA, USA.
Lu TT; Genentech, Inc., South San Francisco, CA, USA.
Maurer M; Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany. .; Allergology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Nov; Vol. 27 (11), pp. 1961-1969. Date of Electronic Publication: 2021 Nov 08.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Agammaglobulinaemia Tyrosine Kinase/*antagonists & inhibitors
Chronic Urticaria/*drug therapy
Histamine H1 Antagonists/*therapeutic use
Histamine Release/*drug effects
Piperazines/*therapeutic use
Pyridones/*therapeutic use
Adolescent ; Adult ; Angioedema/drug therapy ; Autoimmunity/immunology ; Double-Blind Method ; Drug Resistance/physiology ; Female ; Histamine H1 Antagonists/adverse effects ; Humans ; Immunoglobulin E/immunology ; Male ; Mast Cells/metabolism ; Middle Aged ; Piperazines/adverse effects ; Placebos/administration & dosage ; Pyridones/adverse effects ; Receptors, IgE/antagonists & inhibitors ; Transaminases/analysis ; Young Adult
Czasopismo naukowe
Tytuł :
Antihistamine-related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use?
Autorzy :
Oyekan PJ; Institute of Pharmaceutical Sciences, King's College London, London, UK.
Gorton HC; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Copeland CS; Institute of Pharmaceutical Sciences, King's College London, London, UK.; Population Health Research Institute, St George's, University of London, London, UK.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Oct; Vol. 87 (10), pp. 3978-3987. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article
MeSH Terms :
Histamine Antagonists*/adverse effects
Histamine H1 Antagonists*/adverse effects
England/epidemiology ; Humans ; Hypnotics and Sedatives
Czasopismo naukowe
Tytuł :
Newer-generation antihistamines and the risk of adverse events in children: A systematic review.
Autorzy :
Miligkos M; Society of Junior Doctors, Athens, Greece.; First Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Dakoutrou M; Society of Junior Doctors, Athens, Greece.; First Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Statha E; Society of Junior Doctors, Athens, Greece.
Theochari NA; Society of Junior Doctors, Athens, Greece.
Mavroeidi IA; Society of Junior Doctors, Athens, Greece.
Pankozidou Ι; Society of Junior Doctors, Athens, Greece.
Papaconstadopoulos I; Department of Pediatrics, Unterberg Children's Hospital at Monmouth Medical Center, Long Branch, NJ, USA.
Papadopoulos NG; Allergy Department, Second Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK.
Pokaż więcej
Źródło :
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2021 Oct; Vol. 32 (7), pp. 1533-1558. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Histamine Antagonists*
Histamine H1 Antagonists*
Cetirizine/adverse effects ; Child ; Humans
Czasopismo naukowe
Tytuł :
[Sedating antihistamines - risk of severe intoxication].
Autorzy :
Thunander Sundbom L; farm dr, Läkemedelsverket.
Fornstedt Wallin B; Dr med vet, Läkemedelsverket.
Wändel Liminga U; dr med vet, Läkemedelsverket.
Nordmark Grass J; Med dr, Giftinformationscentralen.
K Jönsson A; docent, toxikolog, Linköpings Universitet, Rättsmedicinalverket.
Nurminen ML; Docent, Läkemedelsverket.
Pokaż więcej
Transliterated Title :
Sedativa antihistaminer – risk för allvarlig intoxikation.
Źródło :
Lakartidningen [Lakartidningen] 2021 Sep 30; Vol. 118. Date of Electronic Publication: 2021 Sep 30.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Overdose*/epidemiology
Histamine H1 Antagonists*
Cholinergic Antagonists/adverse effects ; Humans ; Promethazine ; Sweden/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies